Yahoo Web Search

  1. Scpharmaceuticals Inc (NASDAQ: SCPH) Vaxart Inc (NASDAQ: VXRT) Viveve Medical Inc (NASDAQ: VIVE) Teva Pharmaceutical Industries Ltd (NYSE: TEVA) Intercept ...

  2. Stocks recently featured in the blog include: Pfizer PFE, Teva TEVA, Novartis NVS, Merck MRK and AstraZeneca AZN. This week Pfizer and Teva gained marketing approval from ...

  3. Teva Pharmaceutical Industries Ltd said on Tuesday it would stop developing its migraine drug, Ajovy, for treating cluster headaches after the company found the treatment ...

  4. NYSE: MRK) announced FDA approval for its Keytruda as a monotherapy for first-line treatment of patients with stage 3 non-small...

  5. This week Pfizer PFE and Teva TEVA gained marketing approval from the European Commission for their new medicines. While Pfizer gained approval for its new lung cancer medicine ...

  6. Oklahoma's attorney general on Thursday had dropped all but a single claim against Johnson & Johnson and Teva Pharmaceutical Industries Ltd in a closely watched lawsuit ...

  7. Swiss pharma giant Novartis AG NVS announced it is suing partner Amgen AMGN. Both the companies had a development and worldwide commercialization agreement for migraine drug, Aimovig (erenumab ...

  8. BioDelivery (BDSI) Buys US Rights to Pain Drug for $30M

    Zacks via Yahoo FinanceApr 11 13:34 PM

    BioDelivery Sciences International, Inc. BDSI announced that it has inked an exclusive licensing agreement with Japanese pharma company, Shionogi, acquiring U.S. commercial rights to the latter's ...

  9. Supreme Court on Monday cast aside pharmaceutical company Allergan Plc's unorthodox bid to shield patents from a federal administrative court's review by transferring them to a Native ...

  10. Teva to stop developing cluster headache treatment

    Reuters via Yahoo FinanceApr 23 13:13 PM

    Teva Pharmaceutical Industries Ltd said on Tuesday it would stop developing its migraine drug, Ajovy, for treating cluster headaches. The company said the decision ...